INDIA – Dhoot Transmission, one of the largest manufacturers of two-wheeler wiring harnesses, is expanding into the health and wellness segment with a virus neutralizer that will help purify air in enclosed spaces.

The Aurangabad-based company, which has large clients such as Bajaj Auto and Honda Motorcycles & Scooters, launched a slew of health and wellness products on Monday under the label Burge Electronics.

Burge will launch its first product, an ozone-free air purifier with an ion dome for virus neutralization.

Burge Electronics, which has over two decades of experience in product development, manufacturing, and distribution, aims to disrupt the health and wellness industry with safe, affordable, advanced, and innovative solutions, according to Rahul Dhoot, Managing Director of Dhoot Transmission.

Burge Electronics will soon release its first product, ion Dome, a virus neutralizer approved and tested by Indian Council of Medical Research-recognized (ICMR-recognized) and International Laboratory Accreditation Cooperation (ILAC) accredited labs. It also includes air purification technology that uses an ionizer to disinfect the air in enclosed spaces such as the home, office, restaurant, gym, classroom, and cabin, he added.

The ion Dome aims to make enclosed spaces safe at a time when the country is witnessing rapid spreads of SARS-CoV-2 variants.

According to the industry lobby Ficci, the domestic wellness industry is worth around Rs 50,000 crore and has been growing at an exponential rate since the pandemic years.

In the second phase, it will launch more technologically and locally developed wellness products such as car virus neutralizers, anti-aging face masks, and hydrogen water, according to Dhoot, who added that Burge Electronics will be based in Aurangabad.

Dhoot Transmission manufactures other automotive components in addition to wiring harnesses for two-wheelers.

Further afield, GSK has turned down three “unsolicited” offers from Unilever to buy its consumer health business, which the healthcare company claims “fundamentally undervalued” the business and its future prospects.

The most recent proposal, made on December 20, 2021, was for a total value of £50 billion (US$68.1 billion).

Following a 2018 merger, GSK’s consumer healthcare business is a joint venture (JV) with Pfizer. This came after GSK bought out its previous partner Novartis and gained complete control.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE